Pro Vise Management Group, LLC Sanofi Transaction History

Pro Vise Management Group, LLC

$1.16 Billion
Q1 2025

A detailed history of Pro Vise Management Group, LLC transactions in Sanofi stock. As of the latest transaction made, Pro Vise Management Group, LLC holds 193,213 shares of SNY stock, worth $9.54 Million. This represents 0.93% of its overall portfolio holdings.

Number of Shares

193,213

Previous 187,427 3.09%

Holding current value

$9.54 Million

Previous $9.04 Million 18.52%

% of portfolio

0.93%

Previous 0.79%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 08, 2025	BUY	$48.15 - $59.42 $278,595 - $343,804	5,786 Added 3.09%	193,213 $10.7 Million
Q4 2024 Feb 10, 2025	BUY	$45.89 - $57.31 $33,637 - $42,008	733 Added 0.39%	187,427 $9.04 Million
Q3 2024 Nov 12, 2024	BUY	$48.54 - $58.53 $483,749 - $583,309	9,966 Added 5.64%	186,694 $10.8 Million
Q2 2024 Aug 12, 2024	BUY	$45.39 - $50.36 $250,053 - $277,433	5,509 Added 3.22%	176,728 $8.57 Million
Q1 2024 May 09, 2024	BUY	$45.75 - $52.48 $466,055 - $534,613	10,187 Added 6.33%	171,219 $8.32 Million
Q4 2023 Feb 09, 2024	BUY	$43.13 - $54.79 $368,934 - $468,673	8,554 Added 5.61%	161,032 $8.01 Million
Q3 2023 Nov 08, 2023	BUY	$50.95 - $55.2 $180,974 - $196,070	3,552 Added 2.39%	152,478 $8.18 Million
Q2 2023 Aug 24, 2023	SELL	$50.45 - $57.18 $103,069 - $116,818	-2,043 Reduced 1.35%	148,926 $8.03 Million
Q1 2023 May 05, 2023	SELL	$45.86 - $54.45 $672,399 - $798,345	-14,662 Reduced 8.85%	150,969 $8.22 Million
Q4 2022 Feb 09, 2023	SELL	$38.86 - $48.55 $487,304 - $608,817	-12,540 Reduced 7.04%	165,631 $8.02 Million
Q3 2022 Nov 09, 2022	BUY	$37.22 - $100.5 $35,954 - $97,083	966 Added 0.55%	178,171 $6.77 Million
Q2 2022 Aug 08, 2022	BUY	$48.99 - $57.46 $159,168 - $186,687	3,249 Added 1.87%	177,205 $8.87 Million
Q1 2022 Apr 27, 2022	BUY	$48.48 - $53.65 $115,479 - $127,794	2,382 Added 1.39%	173,956 $8.93 Million
Q4 2021 Jan 18, 2022	BUY	$47.07 - $52.35 $435,726 - $484,603	9,257 Added 5.7%	171,574 $8.6 Million
Q3 2021 Oct 20, 2021	BUY	$47.89 - $53.12 $425,502 - $471,971	8,885 Added 5.79%	162,317 $7.83 Million
Q2 2021 Aug 06, 2021	SELL	$49.36 - $54.25 $151,535 - $166,547	-3,070 Reduced 1.96%	153,432 $8.08 Million
Q1 2021 Apr 22, 2021	SELL	$45.46 - $50.51 $56,779 - $63,086	-1,249 Reduced 0.79%	156,502 $7.74 Million
Q4 2020 Jan 19, 2021	SELL	$45.3 - $51.62 $9,513 - $10,840	-210 Reduced 0.13%	157,751 $7.67 Million
Q3 2020 Oct 26, 2020	SELL	$49.47 - $53.77 $24,339 - $26,454	-492 Reduced 0.31%	157,961 $7.93 Million
Q2 2020 Aug 07, 2020	SELL	$42.91 - $52.5 $371,557 - $454,597	-8,659 Reduced 5.18%	158,453 $8.09 Million
Q1 2020 May 07, 2020	SELL	$38.02 - $51.66 $202,494 - $275,141	-5,326 Reduced 3.09%	167,112 $7.31 Million
Q4 2019 Feb 11, 2020	BUY	$44.25 - $50.86 $190,850 - $219,359	4,313 Added 2.57%	172,438 $8.66 Million
Q3 2019 Nov 13, 2019	BUY	$40.34 - $46.64 $1.8 Million - $2.08 Million	44,572 Added 36.08%	168,125 $7.79 Million
Q2 2019 Aug 09, 2019	BUY	$40.43 - $44.3 $171,504 - $187,920	4,242 Added 3.56%	123,553 $5.35 Million
Q1 2019 May 13, 2019	SELL	$40.83 - $45.43 $607,142 - $675,544	-14,870 Reduced 11.08%	119,311 $5.28 Million
Q4 2018 Feb 13, 2019	SELL	$41.48 - $45.59 $290,857 - $319,677	-7,012 Reduced 4.97%	134,181 $5.83 Million
Q3 2018 Nov 05, 2018	SELL	$40.0 - $44.84 $82,680 - $92,684	-2,067 Reduced 1.44%	141,193 $6.31 Million
Q2 2018 Aug 13, 2018	SELL	$37.63 - $41.22 $16,369 - $17,930	-435 Reduced 0.3%	143,260 $12.9 Million
Q1 2018 May 09, 2018	BUY	$38.98 - $45.76 $364,268 - $427,627	9,345 Added 6.96%	143,695 $5.76 Million
Q4 2017 Feb 07, 2018	SELL	$42.86 - $50.61 $507,376 - $599,121	-11,838 Reduced 8.1%	134,350 $5.78 Million
Q3 2017 Nov 08, 2017	BUY	$47.04 - $50.34 $6.88 Million - $7.36 Million	146,188	146,188 $7.28 Million

Others Institutions Holding SNY

# of Institutions

845

Shares Held

269M

Call Options Held

1.71M

Put Options Held

1.76M

View Full List

About Sanofi

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $124B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

More about SNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Vise Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Vise Management Group, LLC with notifications on news.

Account

Pro Vise Management Group, LLC Sanofi Transaction History